We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

FOCUS: First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03846193
Recruitment Status : Active, not recruiting
First Posted : February 19, 2019
Last Update Posted : December 1, 2022
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Gyroscope Therapeutics Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 23, 2023
Estimated Study Completion Date : January 19, 2027